0001493152-21-023533.txt : 20210924 0001493152-21-023533.hdr.sgml : 20210924 20210924095858 ACCESSION NUMBER: 0001493152-21-023533 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210924 DATE AS OF CHANGE: 20210924 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TODOS MEDICAL LTD. CENTRAL INDEX KEY: 0001645260 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91434 FILM NUMBER: 211274834 BUSINESS ADDRESS: STREET 1: 1 HAMADA STREET CITY: REHOVOT STATE: L3 ZIP: 7670301 BUSINESS PHONE: 972546380666 MAIL ADDRESS: STREET 1: 1 HAMADA STREET CITY: REHOVOT STATE: L3 ZIP: 7670301 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Strategic Investment Holdings, LLC CENTRAL INDEX KEY: 0001803803 IRS NUMBER: 821548155 STATE OF INCORPORATION: NV FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 875 CARRETERA 693 STREET 2: SUITE 201 CITY: DORADO STATE: PR ZIP: 00646 BUSINESS PHONE: 787 626 6500 MAIL ADDRESS: STREET 1: 875 CARRETERA 693 STREET 2: SUITE 201 CITY: DORADO STATE: PR ZIP: 00646 SC 13G 1 formsc13g.htm

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. ________)*

 

Todos Medical Ltd.

(Name of Issuer)

 

Ordinary Shares, par value NIS 0.01 per share

(Title of Class of Securities)

 

M8790Y108

(CUSIP Number)

 

August 19, 2021

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

 

 

 

 
CUSIP No.13GPage 2 of 5 Pages

 

1.   NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Strategic Investment Holdings, LLC (ID 82-1548155)
2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)

(b) ☐

3.  

SEC USE ONLY

 

4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

NUMBER OF SHARES BENEFICIALLY OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

60,570,182

 

6.

SHARED VOTING POWER

0

 

7.

SOLE DISPOSITIVE POWER

60,570,182

 

8.

SHARED DISPOSITIVE POWER

 

0

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

60,570,182

 

10.  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) ☐

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.97%

 

12.  

TYPE OF REPORTING PERSON (see instructions)

 

CO

 

-2-
 

 

Item 1.

 

  (a)

Name of Issuer

 

Todos Medical Ltd.

     
  (b)

Address of Issuer’s Principal Executive Offices

 

1 Hamada Street

Rehovot Israel

 

Item 2.

 

  (a)

Name of Person Filing

 

Strategic Investment Holdings, LLC

     
  (b)

Address of the Principal Office or, if none, residence

 

875 Carretera 693, suite 201

Dorado, PR 00646

     
  (c)

Citizenship

USA

     
  (d)

Title of Class of Securities

 

COMMON STOCK PAR VALUE OF 0.01 NIS

     
  (e)

CUSIP Number

 

    M8790Y108

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
  (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
  (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

-3-
 

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)Amount beneficially owned:

 

See Item 9 of the cover page.

 

(b)Percent of class:

 

See Item 11 of the cover page.

 

(c)Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote:
     
    See Item 5 of the cover page.
     
  (ii) Shared power to vote or to direct the vote:
     
    See Item 6 of the cover page.
     
  (iii) Sole power to dispose or to direct the disposition of:
     
    See Item 7 of the cover page.
     
  (iv) Shared power to dispose or to direct the disposition of:
     
    See Item 8 of the cover page.

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not applicable.

 

Item 10. Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

-4-
 

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

   September 24, 2021

Date

   
  /s/ Robb Rill 
 

Signature

   
  Robb Rill/Managing Director

  Name/Title

 

-5-